Pharmaceutical Strategies Group Announces Health Plan Practice Leadership Promotions and Business Transformation Expansion

Investing in Leaders and Capabilities That Help Health Plans Succeed

DALLAS, TX – April 1, 2026 – Pharmaceutical Strategies Group (“PSG”), an EPIC company, announced a series of leadership promotions and an organizational evolution within its Health Plan practice. As the pharmacy benefit landscape becomes more complex across legislative, financial, and operational dimensions, PSG is aligning its leadership and capabilities to help health plans navigate change with clarity and confidence.

“With more options, stakeholders, and rapid change than ever, health plans have a real opportunity to take greater ownership of their pharmacy program and set a stronger path for the future,” said Michael Lonergan, President of PSG. “That takes a clear point of view, disciplined execution, and partners that can translate complexity into decisions. We are investing in leaders and capabilities that help health plans succeed in the market while improving affordability and performance.”

Leadership Promotions

Mike Kolodij, Pharm.D. – Senior Vice President, Health Plans and National Practice Leader
In this expanded role, Mike Kolodij will oversee the delivery of PSG’s Health Plan practice with a focus on strategic planning, client relationship leadership, and operational execution. He has been instrumental in leading complex initiatives and advancing durable, sustainable models for pharmacy benefit management.

Jared Tate, Pharm.D. – Vice President, Health Plan Consulting
Jared Tate will lead the consulting team of the Health Plan practice, ensuring client expectations are met while continuing to develop PSG’s practice. He is recognized for high-impact delivery, steady execution, and a collaborative leadership approach.

Evolving Our Capabilities: Business Transformation and Advisory Services

To support clients across the full lifecycle of transformation, PSG is evolving its Implementation Team into a Business Transformation and Advisory Services organization, extending support from strategy through delivery.

Krista Siano – Vice President, Business Transformation and Advisory Services
Krista Siano will lead this expanded organization, bringing a track record of strategic insight, operational excellence, and a strong commitment to helping clients navigate complexity and drive sustainable outcomes.

Market Growth and Industry Engagement

As part of this evolution, PSG is also announcing a leadership transition designed to further strengthen market-facing engagement and growth across the health plan segment. Beth Hebert-Silvia will step into the role of Executive Principal, Health Plan Client and Market Growth Strategy, focusing on shaping strategic growth across the health plan market and representing PSG and its clients at the highest levels of industry engagement.

“Change is not a disruption, it’s an opportunity. By leaning into it with curiosity and confidence, we position ourselves to advance, innovate, and lead,” said Beth Hebert-Silvia, Executive Principal, Health Plan Client and Market Growth Strategy.

About Pharmaceutical Strategies Group (PSG)

Pharmaceutical Strategies Group, an EPIC company, relentlessly advocates for clients as they navigate complex and ever-changing drug cost management challenges. PSG functions as a strategic partner through industry-leading intelligence and technologies to realize billions of dollars in drug cost savings for clients every year. www.psgconsults.com